HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data
- PMID: 7552482
- DOI: 10.1097/00042560-199510020-00010
HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data
Abstract
This article provides updated estimates of the rate of new HIV infections among participants in New Haven's legal needle exchange program from syringe tracking and testing data. We previously reported that based on data collected from November 1990 through May 1992, the maximum likelihood incidence rate was zero with a 95% confidence interval of 0-10.2 new infections per 100 drug injectors per year. Expanding this data set through August 1993, the same statistical methods yield a maximum likelihood estimate of 1.63 new infections per 100 drug injectors per year with a 95% confidence interval of 0-7.2. Given these data, the null hypothesis of no new infections cannot be rejected, providing further support for the efficacy of New Haven's needle exchange program.
Similar articles
-
HIV incidence among needle exchange participants: estimates from syringe tracking and testing data.J Acquir Immune Defic Syndr (1988). 1994 Feb;7(2):182-9. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8301530
-
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.Am J Med. 1993 Aug;95(2):214-20. doi: 10.1016/0002-9343(93)90263-o. Am J Med. 1993. PMID: 8356986
-
A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?Am J Public Health. 1994 Dec;84(12):1991-4. doi: 10.2105/ajph.84.12.1991. Am J Public Health. 1994. PMID: 7998644 Free PMC article.
-
The role of needle exchange programs in HIV prevention.Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):75-80. Public Health Rep. 1998. PMID: 9722812 Free PMC article. Review.
-
Syringe and needle exchange programs: Part I.South Med J. 1993 Mar;86(3):318-22. doi: 10.1097/00007611-199303000-00014. South Med J. 1993. PMID: 8451672 Review.
Cited by
-
A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs.J Urban Health. 2020 Aug;97(4):448-456. doi: 10.1007/s11524-020-00465-3. J Urban Health. 2020. PMID: 32720298 Free PMC article.
-
Evaluation of Post-Exposure Prophylaxis Utilization Among Human Immunodeficiency Virus Exposed Victims at University of Gondar Comprehensive Specialized Hospital, North West Ethiopia.HIV AIDS (Auckl). 2020 Jan 21;12:59-67. doi: 10.2147/HIV.S221130. eCollection 2020. HIV AIDS (Auckl). 2020. PMID: 32021487 Free PMC article.
-
Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.Harm Reduct J. 2019 May 21;16(1):33. doi: 10.1186/s12954-019-0305-7. Harm Reduct J. 2019. PMID: 31109339 Free PMC article.
-
Antiretroviral medication for preventing HIV infection in nonoccupational settings.CMAJ. 2012 Jul 10;184(10):1153-7. doi: 10.1503/cmaj.120267. Epub 2012 May 28. CMAJ. 2012. PMID: 22641683 Free PMC article. Review. No abstract available.
-
Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community.BMC Public Health. 2009 May 12;9:137. doi: 10.1186/1471-2458-9-137. BMC Public Health. 2009. PMID: 19435512 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical